These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34531230)

  • 41. Acquired FXIII inhibitor: Patient characteristics and treatment outcome, a case series in Taiwan.
    Chou SC; Lin CY; Yen CT; Hsieh HN; Huang YC; Li KJ; Lin SW; Shen MC
    J Formos Med Assoc; 2021 Jan; 120(1 Pt 2):411-414. PubMed ID: 32513506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Catridecacog: a breakthrough in the treatment of congenital factor XIII A-subunit deficiency?
    Korte W
    J Blood Med; 2014; 5():107-13. PubMed ID: 25031548
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Factor XIII cotreatment with hemostatic agents in hemophilia A increases fibrin α-chain crosslinking.
    Beckman JD; Holle LA; Wolberg AS
    J Thromb Haemost; 2018 Jan; 16(1):131-141. PubMed ID: 29080382
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Severe bleeding diatheses in an elderly patient with combined type autoantibody against factor XIII A subunit; novel approach to the diagnosis and classification of anti-factor XIII antibodies.
    Kun M; Szuber N; Katona É; Pénzes K; Bonnefoy A; Bécsi B; Erdődi F; Rivard GE; Muszbek L
    Haemophilia; 2017 Jul; 23(4):590-597. PubMed ID: 28345289
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood coagulation factor XIII and factor XIII deficiency.
    Dorgalaleh A; Rashidpanah J
    Blood Rev; 2016 Nov; 30(6):461-475. PubMed ID: 27344554
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical Use of Factor XIII Concentrates.
    Lassila R
    Semin Thromb Hemost; 2016 Jun; 42(4):440-4. PubMed ID: 27071044
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transient Platelet Dysfunction in Congenital Factor XIII Deficiency with Enhanced Thrombin Generation Potential.
    Oh I; Gu J; Kim HK; Choi JY
    Clin Lab; 2022 Aug; 68(8):. PubMed ID: 35975501
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid immunochromatographic test for detection of anti-factor XIII A subunit antibodies can diagnose 90 % of cases with autoimmune haemorrhaphilia XIII/13.
    Osaki T; Sugiyama D; Magari Y; Souri M; Ichinose A
    Thromb Haemost; 2015 Jun; 113(6):1347-56. PubMed ID: 25740658
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Acquired autoimmune coagulation factor XIII/13 deficiency].
    Ogawa Y
    Rinsho Ketsueki; 2020; 61(7):799-808. PubMed ID: 32759568
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency.
    Jang MA; Park YS; Lee KO; Kim HJ
    Blood Coagul Fibrinolysis; 2015 Jan; 26(1):46-9. PubMed ID: 25004025
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Coagulation factor XIII: a multifunctional transglutaminase with clinical potential in a range of conditions.
    Dickneite G; Herwald H; Korte W; Allanore Y; Denton CP; Matucci Cerinic M
    Thromb Haemost; 2015 Apr; 113(4):686-97. PubMed ID: 25652913
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Factor XIII deficiency - not only a congenital bleeding disorder].
    Schött U; Astermark J; Zdanowski A; Strandberg K
    Lakartidningen; 2023 Apr; 120():. PubMed ID: 37099358
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factor XIII A-Subunit V34L Variant Affects Thrombus Cross-Linking in a Murine Model of Thrombosis.
    Duval C; Ali M; Chaudhry WW; Ridger VC; Ariëns RA; Philippou H
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):308-16. PubMed ID: 26743168
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety and effectiveness of recombinant factor XIII-A
    Poulsen LH; Kerlin BA; Castaman G; Molinari AC; Menegatti M; Nugent D; Dey S; Garly ML; Carcao M
    Res Pract Thromb Haemost; 2022 Feb; 6(2):e12628. PubMed ID: 35243202
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pharmacokinetics of recombinant FXIII (catridecacog) from the MENTOR
    Pasca S; PierGiorgio C; Pea F;
    J Thromb Thrombolysis; 2022 Nov; 54(4):593-596. PubMed ID: 36094687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Long-term prophylaxis in patients with severe congenital factor XIII deficiency is not complicated by inhibitor formation.
    Naderi M; Ahmadinejad M; Hosseini MS; Moradi E; Dorgalaleh A; Shamsizadeh M
    Blood Coagul Fibrinolysis; 2017 Jun; 28(4):276-278. PubMed ID: 27306330
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency: an analysis of International Proficiency testing results.
    Hsu P; Zantek ND; Meijer P; Hayward CP; Brody J; Zhang X; Smock KJ; Van Cott EM
    Semin Thromb Hemost; 2014 Mar; 40(2):232-8. PubMed ID: 24497117
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factor XIII and surgical bleeding.
    Guilabert P; Asmis L; Cortina V; Barret JP; Colomina MJ
    Minerva Anestesiol; 2022 Mar; 88(3):156-165. PubMed ID: 35072429
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Factor XIII topology: organization of B subunits and changes with activation studied with single-molecule atomic force microscopy.
    Protopopova AD; Ramirez A; Klinov DV; Litvinov RI; Weisel JW
    J Thromb Haemost; 2019 May; 17(5):737-748. PubMed ID: 30773828
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines.
    Souri M; Biswas A; Misawa M; Omura H; Ichinose A
    Haemophilia; 2014 Mar; 20(2):255-62. PubMed ID: 24286209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.